Printer Friendly

VIRATEK, INC., LISTS ON THE AMERICAN STOCK EXCHANGE

 NEW YORK, Nov. 16 ~PRNewswire~ -- Viratek, Inc., of Costa Mesa, Calif., commenced trading today on the American Stock Exchange. Trading under ticker symbol "VRA", the company's common stock, which previously traded over-the-counter on the NASDAQ System, opened at 12:15 p.m. Eastern Daylight Time on a quote of 3~8 (bid) to 5~8 (offer) at 1,000 shares. The company has chosen Kalb Voorhis & Company as its specialist unit.
 Viratek, Inc., is engaged in the development of pharmaceutical compounds derived from nucleic acids (DNA and RNA) and their building blocks as well as new biomedical products.
 The company's major focus has been on the development of therapeutically useful antiviral, anticancer and immune-modulating compounds. The company's current development efforts concentrate on the clinical testing of the antiviral Virazole in the treatment of chronic active hepatitis C.
 Virazole has received authorization for commercial sale and marketing in over 40 countries, including the United States, Canada, Western Europe, Eastern Europe, Latin America and the Far East, for a variety of viral infections. In the U.S. and 22 other countries it is authorized in aerosol form for the treatment of infants hospitalized with severe lower respiratory tract infection caused by respiratory syncytial virus.
 "We are pleased to be associated with the American Stock Exchange, particularly as this represents a new plateau in the maturity of our company and our pioneer role in the field of antivirals," said Roberts A. Smith, Ph.D., president of Viratek, Inc.
 For the nine months ended Sept. 30, 1992, Viratek, Inc. reported a net income of $3 million or 21 cents per share, up from $2 million or 14 cents per share for the same period one year earlier.
 The American Stock Exchange is committed to becoming the recognized, premier marketplace for growth companies and derivative securities. By responding to listed company needs and initiating quality services, the Amex finds innovative ways to add value to the expanding community of companies and investors it serves.
 -0- 11~16~92
 ~CONTACT: Paul D. Nobile, manager-equities communications of American Stock Exchange, 212-306-2028~
 (VRA)


CO: Viratek, Inc. ST: California IN: MTC SU:

SH -- NY090 -- 1358 11~16~92 14:08 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 16, 1992
Words:362
Previous Article:GENERAL AMERICAN FORMS ALLIANCE WITH CHEMICAL WASTE MANAGEMENT
Next Article:MAIL BOXES COAST TO COAST ISSUES ANNOUNCEMENT
Topics:


Related Articles
VIRATEK INC. LISTS ON THE AMERICAN STOCK EXCHANGE
VIRATEK REPORTS SECOND QUARTER SALES AND EARNINGS
MEDIALOGIC, INC. LISTS ON THE AMERICAN STOCK EXCHANGE; PREVIOUSLY TRADED ON THE EMERGING COMPANY MARKETPLACE
VIRATEK ANNOUNCES PUBLIC OFFERING
DR. NILS JOHANNESSON ELECTED VIRATEK INC. PRESIDENT
JOHN E. GAIT, M.D., JOINS ICN PHARMACEUTICALS' VIRATEK SUBSIDIARY AS INTERNATIONAL MEDICAL DIRECTOR TO DIRECT VIRAZOLE CLINICAL DEVELOPMENT
AMERICAN STOCK EXCHANGE TRADES COMMON STOCK OF PAB BANKSHARES, INC.
Pan Am Takes Off on the American Stock Exchange
Community Bankshares, Inc. Begins Trading on the AMEX
AMEX Trades Common Stock of U.S.B. Holding Co.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters